PNT2258: Additional Phase II data

Data from 13 patients in an open-label, U.S. Phase II trial showed that 120 mg/m 2 IV PNT2258 on days 1-5 of a 21 day cycle led

Read the full 276 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE